28 institutes get ICMR approval

NEW DELHI: The ICMR has approved 28 out of 113 institutions that showed interest in conducting convalescent plasma therapy trials for Covid patients, according to an official from the top medical body.

Transfusing critically ill Covid-19 patients with convalescent plasma -- a component of blood rich in antibodies from patients who recovered from the disease -so that they can fight of f the disease is a treatment showing promise world over.

“The process for the plasma therapy trials is on; institutions are being approved and patients are being recruited. It will, however, be some time before anything conclusive can be said on the results of this therapy,” said ICMR spokesperson Dr Rajni Kant Srivastava. The ICMR earlier this month came out with a detailed document on the study model using plasma therapy. HTC